skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Levonantradol (Code C1385)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Levonantradol

Definition: A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise mechanism of action is unknown, levonantradol appears to bind and activate the cannabinoid receptors CB1 and/or CB2. (NCI04)

Label: Levonantradol

NCI Thesaurus Code: C1385 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0125660  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Levonantradol HCl

External Source Codes: 
CAS Registry Number 71048-87-8 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 39490
PDQ Open Trial Search ID 39490 (check for NCI PDQ open clinical trial info)
UMLS CUI C0125660

Other Properties:
     Name Value (qualifiers indented underneath)
Chemical_Formula C27H35NO4
code C1385
Contributing_Source FDA
Legacy_Concept_Name Levonantradol
Semantic_Type Organic Chemical
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom